DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
01 1Capecitabine
01 1India
01 1Valid
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : R1-CEP 2014-203 - Rev 00
Status : Valid
Issue Date : 2020-05-07
Type : Chemical
Substance Number : 2762
20
Dr. Reddy's Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their significant offerings is Capecitabine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-203 - Rev 00
This Chemical Type CEP, issued on May 07, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2762 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?